Jim Borel, who currently serves as Chair of the Board, brings over 40 years of experience

filing / Aug 21, 2026 / receipt

Proposal 1: Election of Directors Jeffrey D. Capello Director Since 2022

filing / Aug 21, 2026 / receipt

Operational efficiency efforts underway to drive enhanced productivity and improve profitability

ir_statement / Sep 17, 2026 / receipt

Provided FY27 revenue guidance calling for 3% core revenue growth

ir_statement / Sep 17, 2026 / receipt

Severance, non-cash impairment, and other related exit costs primarily associated with a reduction in our global headcount and global genomics business.

ir_statement / Sep 17, 2026 / receipt

Restructuring (7) 0.1 1.0

ir_statement / Sep 17, 2026 / receipt

Sample collection transition and ramp up costs (4) (1.0) 10.3

ir_statement / Sep 17, 2026 / receipt

Transformation initiatives and related costs (6) 4.4 3.3

ir_statement / Sep 17, 2026 / receipt

3M integration costs

ir_statement / Sep 17, 2026 / receipt

Sample collection transition and ramp up costs

ir_statement / Sep 17, 2026 / receipt

Severance, non-cash impairment, and other related exit costs primarily associated with a reduction in our global headcount and global genomics business.

ir_statement / Sep 17, 2026 / receipt

Transformation initiatives and related costs (2) 4.4 3.3 22.3 9.8

ir_statement / Sep 17, 2026 / receipt